BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 10 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding BioCardia, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 23 | 24 | +1 |
| Shares | 2.98M | 2.65M | −329.1K (−11.0%) |
| Value | $5.78M | $5.49M | −$293.0K (−5.1%) |
New holders (5)
Institutions that held BioCardia, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 27,407 | $57.0K | 0.00% |
| Renaissance Technologies LLC | 13,700 | $28.0K | 0.00% |
| LPL Financial LLC | 11,050 | $23.0K | 0.00% |
| Cutler Group LP | 1,000 | $2.00K | 0.00% |
| IFP Advisors, Inc | 100 | – | – |
Sold out (4)
Institutions that held BioCardia, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Family Management Corp | 142,186 | $276.0K |
| Virtu Financial LLC | 56,419 | $109.0K |
| Two Sigma Securities, LLC | 21,196 | $41.0K |
| Tower Research Capital LLC (TRC) | 2,200 | $4.00K |